Table 1.
Characteristics of 108 patients after propensity score matching
| IA (n = 54) | DAC+IA (n = 54) | P value | |
|---|---|---|---|
| Age, years | |||
| Median | 35 | 35.5 | .902 |
| Range | 15‐57 | 14‐59 | |
| History, months | |||
| Median | 1.0 | 1.0 | .841 |
| Range | 0.2‐7.0 | 0.1‐6.0 | |
| WBC, ×109/L | |||
| Median | 18.25 | 25.00 | .808 |
| Range | 1.44‐361.0 | 1.27‐230.0 | |
| MCV, fL | |||
| Median | 100.6 | 100.4 | .837 |
| Range | 80‐115 | 69‐121 | |
| Blasts, % | |||
| Median | 53.5 | 56.5 | .888 |
| Range | 21.0‐94.0 | 21.0‐91.0 | |
| Gender, n(%) | |||
| Male | 30 (55.6) | 33 (61.1) | .696 |
| Female | 24 (44.4) | 21 (38.9) | |
| FAB category, n(%) | |||
| M0 | 1 (1.9) | 2 (3.7) | .751 |
| M1 | 6 (11.1) | 5 (9.3) | |
| M2 | 22 (40.7) | 19 (35.2) | |
| M4 | 6 (11.1) | 6 (11.1) | |
| M5 | 19 (35.2) | 20 (37.0) | |
| M6 | 0 (0.0) | 2 (3.7) | |
| Dysplasia, n(%) | |||
| 0 | 48 (88.9) | 48 (88.9) | 1.000 |
| 1 | 6 (11.1) | 6 (11.1) | |
| Cytogenetics related to MDS, n(%) | |||
| 0 | 49 (90.7) | 48 (88.9) | 1.000 |
| 1 | 5 (9.3) | 6 (11.1) | |
| NCCN prognostic stratification, n(%) | |||
| Favor | 17 (31.5) | 17 (31.5) | .784 |
| Intermediate | 17 (31.5) | 20 (37) | |
| Poor | 20 (37) | 17 (31.5) | |
Abbreviations: FAB, French‐American‐British classification; MCV, mean corpuscular volume; MDS, myelodysplasia syndrome; WBC, white blood cell.